2,2'-Bipyridinedichloroplatinum

Catalog No. :
ACJTNO807
CAS No. :
13965-31-6
Molecular Formula :
C10H8Cl2N2Pt
Molecular Weight :
422.17

IUPAC Name:-

2,2'-Bipyridinedichloroplatinum structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$61.00Login to see priceIn stockInquiry
250mg96%$89.00Login to see priceIn stockInquiry
1g96%$228.00Login to see priceIn stockInquiry
5g96%$1094.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2'-Bipyridinedichloroplatinum
MDL No.MFCD00191790
Molecular FormulaC10H8Cl2N2Pt
Molecular Weight422.17
SMILESCl[Pt]Cl.C1(C2=CC=CC=N2)=CC=CC=N1
InChI KeyYVQNEQKKLNWXEM-UHFFFAOYSA-L
SynonymF74395 | (2,2'-Bipyridine)dichloroplatinum(II), 96% | (2,2'-Bipyridine)dichloroplatinum(II) | (2,2'-bipyridine)dichloro-platinum(ii) | (2,2/'-BIPYRIDINE)DICHLOROPLATINUM(II) | SCHEMBL1278984 | dichloroplatinum;2-pyridin-2-ylpyridine | DTXSID40422000 | 2,2
CAS No.13965-31-6
PubChem CID6099922

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H332-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352+P312-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJTNO807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRAI571 route compound structure diagram
    ACLRAI5715029-67-4 In Stock
  2. Then
  3. ACJTNO807 route product structure diagram
    ACJTNO80713965-31-6 In Stock
Inquiry

2. ACJTNO807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACJTNO807 route product structure diagram
    ACJTNO80713965-31-6 In Stock
Inquiry

Comments (0)